Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung, Neoplastic Cells, Circulating

NCT03436329 2020-10-12

Reduced Dissemination of Tumor Cells With Primary Ligation of the Vein in Patients With Lung Cancer

Phase NA Unknown

60 enrolled

Thoracic

Lung Neoplasms, Neoplastic Cells, Circulating

NCT03481101 2020-10-08

WHENII

Phase NA Unknown

60 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplastic Cells, Circulating

NCT04315753 2020-03-20

SMAC-2

Unknown

2,000 enrolled

Thoracic

Lung Neoplasms, Neoplastic Cells, Circulating

NCT03645252 2018-08-24

CTC-01

Phase NA Unknown

30 enrolled

Thoracic

Lung Neoplasms, Neoplastic Cells, Circulating

NCT02055144 2017-03-07

Veristrat as Predictor of Benefit of First Line Non Small Cell Lung Cancer (NSCLC) Patients From Standard Chemotherapy

Unknown

100 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplastic Cells, Circulating

NCT02951897 2016-11-02

CTCs detection

Phase NA Unknown

120 enrolled

Thoracic

Adenocarcinoma of Lung, Disease, Neoplastic Cells, Circulating

NCT02507778 2016-09-23

Circulating Tumor Cells Spillage After Pulmonary Biopsy

Phase NA Unknown

40 enrolled

Thoracic

Lung Neoplasms, Neoplastic Cells, Circulating, Neoplasms

NCT02647164 2016-01-06

The Value Of Circulating Tumor Cells In Patient With NSCLC In Postoperative Recurrence Monitoring

Unknown

360 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplastic Cells, Circulating

NCT01052818 2010-01-20

Therapeutic and Prognostic Impact of Circulating Tumor Cells in Peripheral Blood in Patients With Non Small-cell Lung Cancer

Unknown

200 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Neoplastic Cells, Circulating

Clinical Trials

Clinical Significance of Circulating Tumor Cell in Non Small Cell Lung Cancer

Reduced Dissemination of Tumor Cells With Primary Ligation of the Vein in Patients With Lung Cancer

WHENII

SMAC-2

CTC-01

Veristrat as Predictor of Benefit of First Line Non Small Cell Lung Cancer (NSCLC) Patients From Standard Chemotherapy

CTCs detection

Circulating Tumor Cells Spillage After Pulmonary Biopsy

The Value Of Circulating Tumor Cells In Patient With NSCLC In Postoperative Recurrence Monitoring

Therapeutic and Prognostic Impact of Circulating Tumor Cells in Peripheral Blood in Patients With Non Small-cell Lung Cancer